These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 26250981)
1. Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells. Khalife M; Morshedi D; Aliakbari F; Tayaranian Marvian A; Mohammad Beigi H; Azimzadeh Jamalkandi S; Pan-Montojo F Protein J; 2015 Aug; 34(4):291-303. PubMed ID: 26250981 [TBL] [Abstract][Full Text] [Related]
2. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein. Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458 [TBL] [Abstract][Full Text] [Related]
3. Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine. Jain MK; Bhat R Neurobiol Dis; 2014 Mar; 63():115-28. PubMed ID: 24269918 [TBL] [Abstract][Full Text] [Related]
4. α-synuclein aggregation and its modulation. Ghosh D; Mehra S; Sahay S; Singh PK; Maji SK Int J Biol Macromol; 2017 Jul; 100():37-54. PubMed ID: 27737778 [TBL] [Abstract][Full Text] [Related]
5. Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein. Sengupta U; Puangmalai N; Bhatt N; Garcia S; Zhao Y; Kayed R Mol Neurobiol; 2020 Jun; 57(6):2741-2765. PubMed ID: 32350746 [TBL] [Abstract][Full Text] [Related]
6. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease. Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273 [TBL] [Abstract][Full Text] [Related]
7. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation. Chaari A; Eliezer D; Ladjimi M Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760 [TBL] [Abstract][Full Text] [Related]
8. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner. Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420 [TBL] [Abstract][Full Text] [Related]
9. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species. Singh P; Bhat R ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654 [TBL] [Abstract][Full Text] [Related]
10. Dopamine affects the stability, hydration, and packing of protofibrils and fibrils of the wild type and variants of alpha-synuclein. Follmer C; Romão L; Einsiedler CM; Porto TC; Lara FA; Moncores M; Weissmüller G; Lashuel HA; Lansbury P; Neto VM; Silva JL; Foguel D Biochemistry; 2007 Jan; 46(2):472-82. PubMed ID: 17209557 [TBL] [Abstract][Full Text] [Related]
11. PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Thomsen MB; Ferreira SA; Schacht AC; Jacobsen J; Simonsen M; Betzer C; Jensen PH; Brooks DJ; Landau AM; Romero-Ramos M Neurobiol Dis; 2021 Feb; 149():105229. PubMed ID: 33352233 [TBL] [Abstract][Full Text] [Related]
12. GDNF/RET Signaling Pathway Activation Eliminates Lewy Body Pathology in Midbrain Dopamine Neurons. Chmielarz P; Er Ş; Konovalova J; Bandres L; Hlushchuk I; Albert K; Panhelainen A; Luk K; Airavaara M; Domanskyi A Mov Disord; 2020 Dec; 35(12):2279-2289. PubMed ID: 32964492 [TBL] [Abstract][Full Text] [Related]
13. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors. Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299 [TBL] [Abstract][Full Text] [Related]
14. Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins. Jain MK; Singh P; Roy S; Bhat R Biochemistry; 2018 Jul; 57(26):3830-3848. PubMed ID: 29851342 [TBL] [Abstract][Full Text] [Related]
15. Identification of an Alternatively Spliced α-Synuclein Isoform That Generates a 41-Amino Acid N-Terminal Truncated Peptide, 41-syn: Role in Dopamine Homeostasis. Vinnakota RL; Yedlapudi D; Manda KM; Bhamidipati K; Bommakanti KT; RangaLakshmi GS; Kalivendi SV ACS Chem Neurosci; 2018 Dec; 9(12):2948-2958. PubMed ID: 29996045 [TBL] [Abstract][Full Text] [Related]
16. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production. Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083 [TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation. Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503 [TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlates. Gruden MA; Davydova TV; Narkevich VB; Fomina VG; Wang C; Kudrin VS; Morozova-Roche LA; Sewell RD Behav Brain Res; 2014 Apr; 263():158-68. PubMed ID: 24480422 [TBL] [Abstract][Full Text] [Related]